Clinical trial BGOG-cx1/ENGOT-cx1
Randomized double-blind phase II study comparing 3-weekly carboplatin (AUC 5 or 6) + paclitaxel 175 mg/m2 with or without concomitant and maintenance Nintedanib in advanced or recurrent cervical carcinoma
| Cancers | |
|---|---|
| Organ | Uterus |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | BGOG |
| EudraCT Identifier | 2012-004076-19 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02009579 |
| Inclusion criteria | Second line |
| Last update |